NLRP3 and Chronic colitis: With a discerning and inquisitive interest, we read the paper “BAFF Blockade Attenuates DSS-Induced Chronic Colitis via Inhibiting NLRP3 Inflammasome and NF-κB Activation” published in Frontiers in Immunology (1).